Neda Svirtlih

Summary

Affiliation: Clinical Center of Serbia

Publications

  1. ncbi request reprint [Current treatment of chronic hepatitis C]
    Neda Svirtlih
    Institute for Infectious and Tropical Diseases, Clinical Center for Serbia, Belgrade
    Srp Arh Celok Lek 133:202-7. 2005
  2. ncbi request reprint Reduced quality of life in patients with chronic viral liver disease as assessed by SF12 questionnaire
    Neda Svirtlih
    Institute for Infectious and Tropical Diseases, Clinical Centre of Serbia, Medical Faculty, University of Belgrade, Belgrade, Serbia
    J Gastrointestin Liver Dis 17:405-9. 2008
  3. ncbi request reprint Older age at the time of liver biopsy is the important risk factor for advanced fibrosis in patients with chronic hepatitis C
    Neda Svirtlih
    Institute for Infectious and Tropical Diseases, Clinical Centre of Serbia, Medical Faculty, University of Belgrade, Serbia
    Hepatogastroenterology 54:2324-7. 2007
  4. pmc Hepatitis C virus genotypes in Serbia and Montenegro: the prevalence and clinical significance
    Neda Svirtlih
    Institute for Infectious Diseases, Clinical Centre of Serbia, Bul Oslobodjenja 16, Belgrade 11000, Serbia
    World J Gastroenterol 13:355-60. 2007
  5. ncbi request reprint Histopathology of chronic hepatitis C in relation to virus genotype
    Dragan Delic
    Clinical Center of Serbia, Institute of Infective and Tropical Diseases, Belgrade, Serbia
    Vojnosanit Pregl 63:819-25. 2006
  6. ncbi request reprint Characteristics of patients dying from acute viral hepatitis in Serbia
    Neda Svirtlih
    Institute for Infectious and Tropical Diseases Clinical Center of Serbia, Medical Faculty University of Belgrade, Belgrade, Serbia, Yugoslavia
    Turk J Gastroenterol 22:152-7. 2011
  7. ncbi request reprint Treatment of subacute hepatitis B with lamivudine: a pilot study in Serbia
    Dragan Delic
    Institute for Infectious and Tropical Disease, Clinical Center of Serbia, Belgrade, Serbia
    Vojnosanit Pregl 66:199-202. 2009
  8. doi request reprint The influence of single and combined IL28B polymorphisms on response to treatment of chronic hepatitis C
    Ivana Lazarevic
    University of Belgrade, Faculty of Medicine, Belgrade, Serbia
    J Clin Virol 58:254-7. 2013
  9. ncbi request reprint [Chronic hepatitis C virus infection: is there a correlation between HCV genotypes and the level of viremia?]
    Dragan Delic
    Klinicki centar Srbije, Institut za infektivne i tropske bolesti, Beograd
    Med Pregl 59:230-4. 2006
  10. ncbi request reprint [The importance of aminotransferases and platelets count in non-invasive evaluation stages of chronic hepatitis C]
    Sladana Pavić
    Department for Infectious Diseases, General Hospital, Uzice
    Srp Arh Celok Lek 133:262-5. 2005

Collaborators

Detail Information

Publications15

  1. ncbi request reprint [Current treatment of chronic hepatitis C]
    Neda Svirtlih
    Institute for Infectious and Tropical Diseases, Clinical Center for Serbia, Belgrade
    Srp Arh Celok Lek 133:202-7. 2005
    ..Numerous side-effects can occur during treatment. Special population groups without general consensus about the treatment are children, patients with HIV co-infection, persons with renal disease, etc...
  2. ncbi request reprint Reduced quality of life in patients with chronic viral liver disease as assessed by SF12 questionnaire
    Neda Svirtlih
    Institute for Infectious and Tropical Diseases, Clinical Centre of Serbia, Medical Faculty, University of Belgrade, Belgrade, Serbia
    J Gastrointestin Liver Dis 17:405-9. 2008
    ..Quality of life may be reduced in patients with chronic liver diseases. The purpose of this study was to assess the impact of chronic viral liver disease on health-related quality of life (HRQOL)...
  3. ncbi request reprint Older age at the time of liver biopsy is the important risk factor for advanced fibrosis in patients with chronic hepatitis C
    Neda Svirtlih
    Institute for Infectious and Tropical Diseases, Clinical Centre of Serbia, Medical Faculty, University of Belgrade, Serbia
    Hepatogastroenterology 54:2324-7. 2007
    ..In this study, some of demographic, epidemiological and viral data as risk factors for a degree of liver fibrosis were evaluated...
  4. pmc Hepatitis C virus genotypes in Serbia and Montenegro: the prevalence and clinical significance
    Neda Svirtlih
    Institute for Infectious Diseases, Clinical Centre of Serbia, Bul Oslobodjenja 16, Belgrade 11000, Serbia
    World J Gastroenterol 13:355-60. 2007
    ..To investigate the prevalence of hepatitis C virus (HCV) genotypes in Serbia and Montenegro and their influence on some clinical characteristics in patients with chronic HCV infection...
  5. ncbi request reprint Histopathology of chronic hepatitis C in relation to virus genotype
    Dragan Delic
    Clinical Center of Serbia, Institute of Infective and Tropical Diseases, Belgrade, Serbia
    Vojnosanit Pregl 63:819-25. 2006
    ..Thus, the aim of this study was to determine whether the distinct histopathological manifestations of HCV infection might be in relation to the individual virus genotype...
  6. ncbi request reprint Characteristics of patients dying from acute viral hepatitis in Serbia
    Neda Svirtlih
    Institute for Infectious and Tropical Diseases Clinical Center of Serbia, Medical Faculty University of Belgrade, Belgrade, Serbia, Yugoslavia
    Turk J Gastroenterol 22:152-7. 2011
    ..The aim of this study was to identify some of the clinical and laboratory features associated with a fatal outcome in patients dying from acute viral hepatitis in Serbia...
  7. ncbi request reprint Treatment of subacute hepatitis B with lamivudine: a pilot study in Serbia
    Dragan Delic
    Institute for Infectious and Tropical Disease, Clinical Center of Serbia, Belgrade, Serbia
    Vojnosanit Pregl 66:199-202. 2009
    ..Lamivudine has been established as a safe and effective antiviral agent for the treatment of chronic HBV hepatitis...
  8. doi request reprint The influence of single and combined IL28B polymorphisms on response to treatment of chronic hepatitis C
    Ivana Lazarevic
    University of Belgrade, Faculty of Medicine, Belgrade, Serbia
    J Clin Virol 58:254-7. 2013
    ..Three single nucleotide polymorphisms (SNPs) near IL28B gene were shown to be highly predictive of sustained virological response (SVR) in patients with chronic hepatitis C virus (HCV) infection...
  9. ncbi request reprint [Chronic hepatitis C virus infection: is there a correlation between HCV genotypes and the level of viremia?]
    Dragan Delic
    Klinicki centar Srbije, Institut za infektivne i tropske bolesti, Beograd
    Med Pregl 59:230-4. 2006
    ..Hepatitis C virus (HCV) RNA status and HCV genotypes have become extremely important for exact diagnosis, prognosis, duration of treatment and monitoring of antiviral therapy of chronic HCV infection...
  10. ncbi request reprint [The importance of aminotransferases and platelets count in non-invasive evaluation stages of chronic hepatitis C]
    Sladana Pavić
    Department for Infectious Diseases, General Hospital, Uzice
    Srp Arh Celok Lek 133:262-5. 2005
    ..A liver biopsy was performed for every patient and stages of liver fibrosis were evaluated. Both parameters confirmed a positive correlation with liver fibrosis, which can be useful in predicting the progression of chronic hepatitis C...
  11. ncbi request reprint [The role of interferon in the treatment of acute hepatitis C]
    Jasmina Simonović-Babić
    Klinicki centar Srbije, Beograd, Institut za infektivne i tropske bolesti
    Med Pregl 60:322-6. 2007
    ..The aim of this study is to determine whether treatment during the acute phase prevents the development of chronic infection...
  12. ncbi request reprint [The role of lamivudine in the treatment of HBe antigen negative liver cirrhosis]
    Jasmina Simonović-Babić
    Institut za infektivne i tropske bolesti, Klinicki centar Srbije, Beograd
    Med Pregl 59:317-21. 2006
    ..The aim of this study was to evaluate the effectiveness of lamivudine treatment in patients with cirrhosis due to chronic hepatitis B...
  13. ncbi request reprint Re: Prediction of liver fibrosis in patients with chronic hepatitis B
    Neda Svirtlih
    Hepatogastroenterology 55:preceding table of contents. 2008
  14. ncbi request reprint Treatment of anicteric acute hepatitis C with peginterferon alpha-2a plus ribavirin
    Dragan Delic
    Clinical Center of Serbia, Institute of Infectious and Tropical Diseases, Belgrade
    Vojnosanit Pregl 62:865-8. 2005
    ..Therefore, the causal treatment of patients with acute hepatitis C aimed at the prevention of chronic liver disease is necessary...
  15. ncbi request reprint [Autoantibodies characteristic for autoimmune hepatitis found in chronic hepatitis C]
    Slanjana Pavić
    Department of Infectious Diseases, General Hospital, Uzice
    Srp Arh Celok Lek 131:437-42. 2003
    ....